findmyKOL
Clinical trialNCT00709592CompletedPhase 2Interventional

Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT

SponsorVirginia Commonwealth UniversityEnrollment42Acute Myeloid LeukemiaChronic Lymphocytic LeukemiaChronic Myelogenous LeukemiaHodgkin LymphomaLeukemiaMultiple Myeloma+2 more conditions
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

One of two different doses of thymoglobulin will allow bone marrow engraftment with minimal Graft-versus-Host Disease and allow adequate immune response to allow the transplanted stem cells to replace the tumor cells.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Virginia Commonwealth University/massey Cancer Center

    Richmond, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
21 Jul 2008
Primary completion
15 Feb 2014
Completion
28 Jun 2017
Last update posted
9 Nov 2018
Registered enrollment
42
Registry id
NCT00709592

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.